Short-term intra-arterial infusion of monocyte chemoattractant protein-1 results in sustained collateral artery growth

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 12, Issue 1, 2007, Pages 61-68

  Seidler, Randolph W ^a   Lenter, Martin C ^b   Guth, Brian D ^b   Doods, Henri ^b  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Animals; Arteriogenesis; Cardiovascular pharmacology; Monocyte chemoattractant protein 1; Peripheral arterial disease

Indexed keywords

BIWH 3; GLUTAMINE MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PYROGLUTAMATE MONOCYTE CHEMOTACTIC PROTEIN 1; RECOMBINANT HUMAN MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTERY DILATATION; ARTERY LIGATION; ARTICLE; COLLATERAL CIRCULATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INFUSION; DRUG POTENCY; FEMALE; FEMORAL ARTERY; IN VITRO STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHARMACODYNAMICS; PRIORITY JOURNAL; SHORT COURSE THERAPY; SWINE; TREATMENT DURATION;

ANIMALS; ARTERIES; CHEMOKINE CCL2; CHO CELLS; COLLATERAL CIRCULATION; CRICETINAE; CRICETULUS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEMORAL ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIGATION; MALE; PERIPHERAL VASCULAR DISEASES; RECEPTORS, CHEMOKINE; RECOMBINANT PROTEINS; SWINE; SWINE, MINIATURE; TIME FACTORS; TREATMENT OUTCOME;

EID: 34247610787     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/1074248406298625     Document Type: Article

References (32)

1. Criqui MH, Fronek A., Barrett-Connor E., Klauber MR, Gabriel S., Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985 ; 71: 510-515.
2. Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med. 1997 ; 2: 221-226.
3. Hiatt WR, Hoag S., Hamman RF Effect of diagnostic criteria on the prevalence of peripheral arterial disease: The San Luis Valley Diabetes Study. Circulation. 1995 ; 91: 1472-1479.
4. Dormandy JA, Rutherford RB Management of peripheral arterial disease (PAD): TASC Working Group: TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg. 2000 ; 31: S1 - S296.
5. Criqui MH, Langer RD, Fronek A., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992 ; 326: 381-386.
6. Regensteiner JG, Hiatt WR Current medical therapies for patients with peripheral arterial disease: a critical review. Am J Med. 2002 ; 112: 49-57.
7. Palmer-Kazen U., Wariaro D., Luo F., Wahlberg E. Vascular endothelial cell growth factor and fibroblast growth factor 2 expression in patients with critical limb ischemia. J Vasc Surg. 2004 ; 39: 621-628.
8. McDaniel MD, Cronenwett JL Basic data related to the natural history of intermittent claudication. Ann Vasc Surg. 1989 ; 3: 273-277.
9. Simons M. Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed ? J Am Coll Cardiol. 2005 ; 46: 835-837.
10. Schaper W., Buschmann I. Arteriogenesis, the good and bad of it. Cardiovasc Res. 1999 ; 43: 835-837.
11. de Muinck ED, Simons M. Re-evaluating therapeutic neovascularization. J Mol Cell Cardiol. 2004 ; 36: 25-32.
12. Charo IF, Myers SJ, Herman A., Franci C., Connolly AJ, Coughlin SR Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci USA. 1994 ; 91: 2752-2756.
13. Ito WD, Arras M., Winkler B., Scholz D., Schaper J., Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res. 1997 ; 80: 829-837.
14. Arras M., Ito WD, Scholz D., Winkler B., Schaper J., Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest. 1998 ; 101: 40-50.
15. Buschmann I., Heil M., Jost M., Schaper W. Influence of inflammatory cytokines on arteriogenesis. Microcirculation. 2003 ; 10: 371-379.
16. Voskuil M., van RN, Hoefer IE, et al. Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1. Am J Physiol Heart Circ Physiol. 2003 ; 284: H1422 - H1428.
17. Muhs A., Lenter MC, Seidler RW, et al. Nonviral monocyte chemoattractant protein-1 gene transfer improves arteriogenesis after femoral artery occlusion. Gene Ther. 2004 ; 11: 1685-1693.
18. Heil M., Ziegelhoeffer T., Wagner S., et al. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ Res. 2004 ; 94: 671-677.
19. Buschmann I., Schaper W. Arteriogenesis versus angiogenesis: two mechanisms of vessel growth. News Physiol Sci. 1999 ; 14: 121-125.
20. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000 ; 6: 389-395.
21. Eitenmuller I., Volger O., Kluge A., et al. The range of adaptation by collateral vessels after femoral artery occlusion. Circ Res. 2006 ; 99: 656-662.
22. Yu J., deMuinck ED, Zhuang Z., et al. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci USA. 2005 ; 102: 10999-11004.
23. Scholz D., Ito W., Fleming I., et al. Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch. 2000 ; 436: 257-270.
24. Grundmann S., Hoefer I., Ulusans S., et al. Granulocytemacrophage colony-stimulating factor stimulates arteriogenesis in a pig model of peripheral artery disease using clinically applicable infusion pumps. J Vasc Surg. 2006 ; 43: 1263-1269.
25. Lederman RJ, Mendelsohn FO, Anderson RD, et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet. 2002 ; 359: 2053-2058.
26. Hoefer IE, van RN, Jost MM Experimental models of arteriogenesis: differences and implications. Lab Anim. 2006 ; 35: 36-44.
27. Hoefer IE, van RN, Buschmann IR, Piek JJ, Schaper W. Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res. 2001 ; 49: 609-617.
28. Zimmermann R., Arras M., Ullmann C., et al. Time course of mitosis and collateral growth following coronary microembolization in the porcine heart. Cell Tissue Res. 1997 ; 287: 583-590.
29. White FC, Carroll SM, Magnet A., Bloor CM Coronary collateral development in swine after coronary artery occlusion. Circ Res. 1992 ; 71: 1490-1500.
30. Roth DM, Maruoka Y., Rogers J., White FC, Longhurst JC, Bloor CM Development of coronary collateral circulation in left circumflex Ameroid-occluded swine myocardium. Am J Physiol. 1987 ; 253: H1279 - H1288.
31. Unger EF Experimental evaluation of coronary collateral development. Cardiovasc Res. 2001 ; 49: 497-506.
32. Shou M., Thirumurti V., Rajanayagam S., et al. Effect of basic fibroblast growth factor on myocardial angiogenesis in dogs with mature collateral vessels. J Am Coll Cardiol. 1997 ; 29: 1102-1106.